Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

GABA falls short for type 1 diabetes prevention in children

Publish date:: October 29, 2019

Key clinical point: Gamma aminobutyric acid alone or combined with glutamic acid decarboxylase has little to no effect on the progression of type 1 diabetes in children.

Major finding: There was no difference in pancreatic beta-cell function as measured by meal-stimulated C-peptide levels.

Study details: A 1-year prospective, randomized, double-blind, placebo-controlled trial in 97 children with type 1 diabetes.

Disclosures: The University of Alabama at Birmingham sponsored the study. Collaborators included Diamyd, NOW Foods, Janssen, and the Juvenile Diabetes Research Foundation. Dr. McCormick did not have any disclosures.

Citation:

McCormick KL et al. EASD 2019, Abstract S05.1.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,